Virtu Financial LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Virtu Financial LLC

$1.31 Billion
Q1 2024

A detailed history of Virtu Financial LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 125,974 shares of DNA stock, worth $41,571. This represents 0.01% of its overall portfolio holdings.

Number of Shares

125,974

Previous 198,379 36.5%

Holding current value

$41,571

Previous $335,000 56.42%

% of portfolio

0.01%

Previous 0.03%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	SELL	$1.06 - $1.67 $76,749 - $120,916	-72,405 Reduced 36.5%	125,974 $146,000
Q4 2023 Feb 26, 2024	SELL	$1.26 - $1.79 $223,453 - $317,445	-177,344 Reduced 47.2%	198,379 $335,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $604,914 - $954,336	375,723 New	375,723 $680,000
Q1 2023 May 01, 2023	BUY	$1.2 - $2.19 $502,626 - $917,292	418,855 Added 1591.88%	445,167 $592,000
Q4 2022 Feb 15, 2023	SELL	$1.63 - $3.52 $166,908 - $360,440	-102,398 Reduced 79.56%	26,312 $44,000

Q3 2022 Nov 07, 2022	SELL	$0.73 - $3.74 $220,342 - $1.13 Million	-301,839 Reduced 70.11%	128,710 $402,000
Q2 2022 Aug 09, 2022	BUY	$2.2 - $4.2 $947,207 - $1.81 Million	430,549 New	430,549 $1.03 Million
Q1 2022 May 17, 2022	SELL	$2.83 - $8.69 $246,048 - $755,534	-86,943 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$8.31 - $14.92 $433,690 - $778,659	-52,189 Reduced 37.51%	86,943 $722,000
Q3 2021 Nov 12, 2021	BUY	$9.15 - $13.28 $1.27 Million - $1.85 Million	139,132 New	139,132 $1.61 Million

Others Institutions Holding DNA

# of Institutions

360

Shares Held

1.26B

Call Options Held

845K

Put Options Held

2.54M

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $425M
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account

Virtu Financial LLC Ginkgo Bioworks Holdings, Inc. Transaction History